The effect of EBV targeting was specific to EBV-positive cells, as transduction of EBNA-1 gRNAs into EBV-negative NPC cells had no effects on the levels of phospho-AKT and HIF-1α (Supplementary Fig. 5b). The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.